ENT Devices – Market Insights – Europe

The European ENT device market will grow marginally over the forecast period, driven primarily by the faster-growing balloon dilation device and nasal packing segments. Slight FESS procedure volume growth and a gradual shift toward resorbable nasal packing will support market revenues; however, most ENT procedure volumes in Europe will only see marginal growth through 2033, as an effect of adoption of alternative treatments, such as antibiotics, instead of surgery, hindering the pace of market expansion.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for ENT devices in Europe from 2019 through 2033.

ENT procedures volumes are expected to be almost stagnant through 2033.

Are there any procedures that can still observe substantial growth?

Why are certain ENT procedures declining? Which procedures are replacing them?

How will physician and patient preferences impact procedure uptake?

The introduction of innovative devices like balloon dilation devices and newer treatments will drive overall market expansion.

How will newer treatments impact the uptake of traditional procedures?

What advantages do balloon dilation procedures offer?

How will balloon sinus dilation and balloon Eustachian tube dilation devices perform going forward?

Manufacturers are attempting to broaden their portfolios by entering into newer segments, creating competition for established market leaders.

Which segments are seeing competitors with new products emerge?

How will mergers and acquisitions impact market share dynamics?

Which market segments hold potential for faster growth?

ENT device reuse and reprocessing trends vary across European countries.

How will different market segments be affected by reprocessing requirements?

How will this impact the market in terms of ASPs and unit sales?

How do the constituent countries differ in their approach and extent of reprocessing?